Research progress of cerebral hyperperfusion syndrome
Abstract
Cerebral hyperperfusion syndrome (CHS) is a rare syndrome deriving from carotid endovascular treatment with a high mortality. CHS can be derived by carotid endarterectomy (CEA), carotid artery stenting (CAS) and intracranial artery stenting. This review aims to summarize the progress of clinical manifestations, risk factors, pathogenesis, diagnostic criteria, prevention and treatment for CHS in recent years.
DOI: 10.3969/j.issn.1672-6731.2017.12.003
Keywords
Hemoperfusion; Brain; Angioplasty; Stents; Postoperative complications; Review
This work is licensed under a Creative Commons Attribution 3.0 License.